|
Greetings!
Each week it is our intention to update you on our progress as we
move toward our opening and to give you some information about the
problem that we are dedicated to handling.
| Construction Progress |
 |
|
We are delighted to report that we are now one week closer
to opening our facility and being able to help people safely
and sanely withdraw from prescription drugs, alcohol, and
other opiates. The attached picture is a rendering of how our
patient rooms will look when we have completed our
renovations.
This week the plumbing contractor is in the building
cutting the concrete slab so that the new bathrooms can be
added. This will take until the end of next week but is
necessary before any of the other trades can start their work.
|
| In The News |
|
 While many of us have known that anti-depressants don’t
work and are in fact harmful, many in the medical community
are coming to this same conclusion. On March 23, 2006, the New
England Journal of Medicine published two articles which
pointed out that 70 percent of people taking antidepressants
for depression are still depressed. One article describes a
study of 565 subjects who took the antidepressant (Celexa) for
12 weeks and were still depressed. The researchers continued
to give the subjects Celexa but added another antidepressant.
The result—70 percent of the subjects now taking two dangerous
antidepressants were still depressed. The second article
discusses a study where 727 subjects were taking Celexa and
were still depressed. The subjects were divided into groups
and one group was given Wellbutrin SR, another Zoloft, and
another Effexor XR. These results were even worse than the
first study because at the end of the trial, 75 percent of the
subjects were still depressed. Anti-depressants don’t work and
people need to safely and sanely withdraw from these harmful
drugs and find a real solution.
|
| We Have To Help |
|
|
The FDA is really not watching out for us. According to the
2003 report of the Office of Inspector General of the
Department of Health and Human Services, a survey of CDER
reviewers revealed that 66% lacked confidence in the FDA's
safety monitoring of marketed prescription drugs, and 18% had
felt pressure to approve a drug despite reservations about its
quality, efficacy, or safety. In 2006, the Government
Accountability Office found that the "FDA lacks clear and
effective processes for making decisions about, and providing
management oversight of, post-market safety issues."
|
|
|
Brent Agin, MD
|
|
|
|
Dr. Agin, our medical director, is board certified in
Family Medicine. He attended medical school at the Michigan
State University College of Human Medicine. He completed his
internship and residency at the University of South Florida
College of Medicine.
|
|
